ACT

OCTOBER 29/2019

news roundup

Oracle, Phlexglobal Team on eTMF Integration

Oracle Health Science and Phlexglobal, a provider of Trial Master File (TMF) technology and services for the global life sciences industry, have announced the integration of the latter's TMF solution with the former's eClinical platform.


TrialScope Acquires Advocacy-Focused Platform for Finding Trials

TrialScope has acquired Clinical Trial Connect. Both parties use their platforms to help patients find clinical trials, TrialScope Engage does so via sponsor websites; Clinical Trial Connect reaches patients through advocacy sites. TrialScope plans on leveraging the technology behind Clinical Trial Connect to enhance its own platform.


advertisement

Anti-Microbial Resistance and the Role of Vaccines
Europe: Thursday, November 14, 2019 at 3pm GMT | 4pm CET
North America: Thursday, November 21, 2019 at 11am EST | 10am CST | 8am PST
Register Now



In this edition

Please Take Our Salary Survey!
TrialScope Acquires Advocacy-Focused Platform for Finding Trials
EU Rare Disease Network Open to New Members

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »



Latest Business and People News

Updated each mid-month, this month's moves and news include CTI Consulting, SGS, Synteract, Sharp Clinical Services, Tufts CSDD, BioIVT, Parexel, Pharm-Olam, Experic, Advanced Clinical, PHASTAR, Syneos Health, Rho, Almac Pharma Services, SCORR Marketing, ERT, Clinithink, Signant Health, Novotech, PPD, and MMS Holdings.


Please Take Our Salary Survey!

Applied Clinical Trials and SCORR Marketing will present the findings of our salary and job satisfication survey in the January 2020 issue. Your responses are confidential and information presented in the aggregate.


advertisement

Trends and Insights for Your Oncology Trial Tuesday, November 12, 2019 at 10am EST
Register Now


Articles

Specialty Labs Role in Personalized Clinical Trials

This article describes a study utilizing specialty lab services to perform drug assessment as part of a new personalized medicine clinical trial designed to identify the most effective therapies for individual patients with lymphoma. This novel study was conducted at The University of Texas MD Anderson Cancer Center.

advertisement

Launching Medical Devices in the Japanese Market
How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
Register Now


Biopharma Slow to Adopt RBM

Despite FDA efforts, biopharma companies have been slow to adopt RBM approaches, as seen at a public workshop in July organized by the Margolis Center for Health Policy at Duke University to gain more feedback from stakeholders on the challenges and barriers influencing the adoption of RBM.


advertisement

Will Decentralized Clinical Trials Compound Patient and Data Quality Risks?
Tuesday, October 29, 2019 at 1pm EDT | 12pm CDT| 10am PDT
REGISTER NOW

Events

IRT 2019, 9th Annual Interactive Response Technologies in Clinical Trials
eCOA/ePRO 2019
Risk-Based Trial Management and Monitoring
Clinical Trial Financial Management
Search Upcoming Events

advertisement

GrantPlan: Create Grant Budgets with Confidence and Accuracy
On Demand


Blog Posts

IRT's Conference Starts Today!

CBI is holding its two-day conference to address how RTSM, IWRS, IRT can influence trends including complex trial designs, direct-to-patient or decentralized trials, study startup, blockchain and more.


advertisement

Begin with the End in Mind: The Strategic Benefit of Coordinating Site Budgeting, Contracting, & Payments
On Demand


EU Rare Disease Network Open to New Members

Until November 30, hospital-based specialists in the EU can apply to become members of one of the 24 European Reference Networks (ERNs) that the European Union launched in 2017. The aim is to allow these specialists in Europe to share their experience with complex patient cases, and to provide advice on diagnosis and treatment.

advertisement

How AI/ML and advanced techniques are enhancing clinical development
Lessons learned from use in study design, patient and site ID, safety, and risk-based monitoring
On Demand


Using Clinical Supply as a Patient Centric Tool

A flexible, just in time manufacturing strategy is one way sponsors can foster a co-existence between patient centricity and cost-effective clinical supply chain management, says the author.

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
TBaker@mmhgroup.com